• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form S-8 filed by GoHealth Inc.

    7/18/25 3:54:23 PM ET
    $GOCO
    Specialty Insurers
    Finance
    Get the next $GOCO alert in real time by email
    S-8 1 goco-sx8x7172025.htm S-8 Document


    As filed with the Securities and Exchange Commission on July 18, 2025

    Registration No. 333-

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549



    FORM S-8

    REGISTRATION STATEMENT UNDER
    THE SECURITIES ACT OF 1933



    GoHealth, Inc.
    (Exact name of registrant as specified in its charter)
    DELAWARE
    (State or other jurisdiction of incorporation or organization)
    85-0563805
    (IRS Employer Identification No.)

    222 W Merchandise Mart Plaza, Suite 1750, Chicago, Illinois 60654
    (Address of Principal Executive Offices) (ZIP Code)

    GOHEALTH, INC. SECOND AMENDED AND RESTATED 2020 INCENTIVE AWARD PLAN
    (Full title of the plan)


    BRADLEY BURD
    Chief Legal Officer
    GoHealth, Inc.
    222 W Merchandise Mart Plaza, Suite 1750
    Chicago, Illinois 60654
    (Name and address of agent for service)

    (312) 386-8200
    (Telephone number, including area code, of agent for service)



    Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act of 1934.




    Large accelerated filer
    ☐
    Accelerated filer
    ☐
    Non-accelerated filer
    ☒
    Smaller reporting company
    ☒
    Emerging growth company
    ☐

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐







    EXPLANATORY NOTE

    This Registration Statement on Form S-8 is being filed by GoHealth, Inc. (the “Company”) with the Securities and Exchange Commission (the “Commission”) for the purpose of registering an additional 225,000 shares of the Company’s Class A Common Stock, par value $0.0001 per share (“Common Stock”), issuable under the Company’s Second Amended and Restated 2020 Incentive Award Plan.

    Pursuant to Instruction E of Form S-8, the contents of the Registration Statements on Form S-8 filed with the Commission on July 15, 2020 (File No. 333-239879), February 10, 2021 (File No. 333-252962), March 23, 2022 (File No. 333-263787), June 6, 2022 (File No. 333-265442), January 13, 2023 (File No. 333-269223), March 20, 2024 (file No. 333-278112), and March 6, 2025 (File No. 333-285605) are incorporated by reference herein; except for Items 3 and 8 which are being updated by this Registration Statement.

    PART II
    INFORMATION REQUIRED IN THE REGISTRATION STATEMENT

    Item 3. Incorporation of Documents by Reference.

    The following documents, which have been filed with the Commission by the Company are incorporated in this Registration Statement by reference (excluding any portions of such documents that have been “furnished” but not “filed” for purposes of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)):

    1.The Registrant’s Annual Report on Form 10-K for the fiscal year ended December 31, 2024, filed with the Commission on February 27, 2025;

    2.The Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2025, filed with the Commission on May 16, 2025;

    3.The Company’s Current Reports on Form 8-K filed with the Commission on April 7, 2025, June 20, 2025, and June 30, 2025; and

    4.The description of the Company’s Common Stock contained in the Company’s Registration Statement on Form 8-A dated July 15, 2020 (File No. 001-39390) filed under the Exchange Act, including any amendment or report filed for the purpose of updating such description.

    All documents subsequently filed by the Company with the Commission pursuant to Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act after the date of this Registration Statement and prior to the filing of a post-effective amendment to this Registration Statement which indicates that all securities offered hereby have been sold or which deregisters all securities then remaining unsold, shall be deemed to be incorporated by reference herein and to be a part hereof from the respective dates of filing of such documents (such documents, and the documents enumerated above, being hereinafter referred to as “Incorporated Documents”).

    Any statement contained in an Incorporated Document shall be deemed to be modified or superseded for purposes of this Registration Statement to the extent that a statement contained herein or in any other subsequently filed Incorporated Document modifies or supersedes such statement. Any such statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this Registration Statement.

    Item 8. Exhibits.

    The Exhibits listed on the accompanying Index to Exhibits are filed as part hereof, or incorporated by reference into, this Registration Statement. See Exhibit Index below.






    EXHIBIT INDEX

    Exhibit NumberExhibit Index
    4.1
    Amended and Restated Certificate of Incorporation of GoHealth, Inc. (incorporated by reference to Exhibit 3.1 to the Company’s Quarterly Report on Form 10-Q (File No. 001-39390), filed on August 20, 2020 with the Commission)
    4.2
    Certificate of Amendment to Amended and Restated Certificate of Incorporation of GoHealth, Inc. (incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K (File No. 001-39390), filed on November 18, 2022 with the Commission)
    4.3
    Amended and Restated Bylaws of GoHealth, Inc. (incorporated by reference to Exhibit 3.2 to the Quarterly Report on Form 10-Q (File No. 001-39390), filed on August 20, 2020 with the Commission)
    5.1*
    Opinion of Sidley Austin LLP
    23.1*
    Consent of Ernst & Young LLP
    23.2*
    Consent of Sidley Austin LLP (included in Exhibit 5.1)
    24.1*
    Power of Attorney (included on the signature page hereto)
    99.1
    GoHealth, Inc. Second Amended and Restated 2020 Incentive Award Plan (incorporated by reference to Appendix A to the Company’s Definitive Proxy Statement, filed on April 28, 2025 with the Commission).
    107*
    Filing Fee Table
    __________________
    * Filed herewith.







    SIGNATURES

    Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Chicago, State of Illinois, on July 18, 2025.
    GOHEALTH, INC.
    By/s/ Vijay Kotte
    Vijay Kotte
    Chief Executive Officer








    POWER OF ATTORNEY

    Each of the undersigned officers and directors of GoHealth, Inc. hereby constitutes and appoints Vijay Kotte and Brendan Shanahan, and each of them any of whom may act without joinder of the other, the individual’s true and lawful attorneys-in-fact and agents, each with full power of substitution and resubstitution, for the person and in his or her name, place and stead, in any and all capacities, to sign this Registration Statement and any and all amendments (including post-effective amendments) to this Registration Statement and all documents relating thereto, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto such attorneys-in-fact and agents, each acting alone, full power and authority to do and perform each and every act and thing necessary or advisable to be done in and about the premises, as fully to all intents and purposes as such person might or could do in person, hereby ratifying and confirming all that such attorneys-in-fact and agents, each acting alone, or such person’s substitute or substitutes, lawfully may do or cause to be done by virtue hereof.

    Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.



    SignatureTitleDate
    /s/ Vijay KotteChief Executive Officer and Director (Principal Executive Officer)July 18, 2025
    Vijay Kotte
    /s/ Brendan ShanahanChief Financial Officer (Principal Financial and Accounting Officer)July 18, 2025
    Brendan Shanahan
    /s/ Clinton P. JonesDirectorJuly 18, 2025
    Clinton P. Jones
    /s/ Brandon M. CruzDirectorJuly 18, 2025
    Brandon M. Cruz
    /s/ David FisherDirectorJuly 18, 2025
    David Fisher
    /s/ Jeremy W. GelberDirectorJuly 18, 2025
    Jeremy W. Gelber
    /s/ Karolina Hanna HiluDirectorJuly 18, 2025
    Karolina Hanna Hilu
    /s/ Abhiraj R. ModiDirectorJuly 18, 2025
    Abhiraj R. Modi



    /s/ Alexander E. TimmDirectorJuly 18, 2025
    Alexander E. Timm
    /s/ Alan WheatleyDirectorJuly 18, 2025
    Alan Wheatley

    Get the next $GOCO alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $GOCO

    DatePrice TargetRatingAnalyst
    4/1/2022$1.50Underperform
    Credit Suisse
    3/3/2022$10.00 → $2.00Outperform → Sector Perform
    RBC Capital
    3/2/2022Buy → Hold
    Truist
    3/2/2022$2.00Buy → Hold
    Truist Securities
    1/7/2022$6.00 → $3.00Neutral → Underperform
    Credit Suisse
    1/5/2022$7.50 → $3.50Buy → Underperform
    B of A Securities
    11/15/2021$7.00 → $6.00Neutral
    Credit Suisse
    11/11/2021$13.00 → $5.50Equal-Weight
    Morgan Stanley
    More analyst ratings

    $GOCO
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    New insider Public Sector Pension Investment Board claimed ownership of 1,680,526 shares (SEC Form 3)

    3 - GoHealth, Inc. (0001808220) (Issuer)

    8/15/25 10:03:07 AM ET
    $GOCO
    Specialty Insurers
    Finance

    Chief Executive Officer Kotte Vijay was granted 218,551 shares, increasing direct ownership by 19% to 1,347,396 units (SEC Form 4)

    4 - GoHealth, Inc. (0001808220) (Issuer)

    8/8/25 4:57:12 PM ET
    $GOCO
    Specialty Insurers
    Finance

    SEC Form 3 filed by new insider Carr Alan Jeffrey

    3 - GoHealth, Inc. (0001808220) (Issuer)

    8/8/25 2:44:30 PM ET
    $GOCO
    Specialty Insurers
    Finance

    $GOCO
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    GoHealth Announces Strategic Capital and Governance Actions to Support Long-Term Value Creation and Reports Second Quarter 2025 Results

    CHICAGO, Aug. 07, 2025 (GLOBE NEWSWIRE) -- GoHealth, Inc. (NASDAQ:GOCO) ("GoHealth" or the "Company"), a leading health insurance marketplace and Medicare-focused digital health company, today announced the execution of strategic capital and governance actions that are expected to significantly enhance its financial flexibility and long-term positioning along with its financial results for the three and six months ended June 30, 2025. Strategic Capital and Governance Actions Secured new senior secured superpriority term loan facility, including $80.0 million in new-money term loans and $35.0 million in roll-up loans, to support working capital and stra

    8/7/25 7:00:00 AM ET
    $GOCO
    Specialty Insurers
    Finance

    GoHealth to Announce Strategic Capital and Governance Actions to Support Long-Term Value Creation and Second Quarter 2025 Results

    CHICAGO, Aug. 06, 2025 (GLOBE NEWSWIRE) -- GoHealth, Inc. (GoHealth) (NASDAQ:GOCO), a leading health insurance marketplace and Medicare-focused digital health company, will announce strategic capital and governance actions to support long-term value creation and its second quarter 2025 financial results on the morning of August 7, 2025. Chief Executive Officer, Vijay Kotte, and Chief Financial Officer, Brendan Shanahan, will host a conference call and live audio webcast on the day of the release at 8:00 a.m. (ET) to discuss recent strategic capital and governance actions. A live audio webcast of the conference call will be available via GoHealth's Investor Relations websi

    8/6/25 4:15:00 PM ET
    $GOCO
    Specialty Insurers
    Finance

    GoHealth Secures Amended Credit Agreement Highlighting Broad Based Support from Stakeholders

    CHICAGO, June 30, 2025 (GLOBE NEWSWIRE) -- GoHealth, Inc. (NASDAQ:GOCO), a leading health insurance marketplace, today announced it has entered into an amendment with its lenders under the Company's existing credit agreement in order to, among other things, provide covenant adjustments as well as extend the maturity of the Company's revolving credit facility through September 30, 2025. The amendment also provides consent for the Company to pursue a receivables financing (such consent also covering a securitization transaction) as the parties continue to work toward a comprehensive financing plan intended to alleviate the Company's recent going concern position, strengthen the Company's fin

    6/30/25 4:30:00 PM ET
    $GOCO
    Specialty Insurers
    Finance

    $GOCO
    SEC Filings

    View All

    GoHealth Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    8-K - GoHealth, Inc. (0001808220) (Filer)

    8/19/25 4:20:38 PM ET
    $GOCO
    Specialty Insurers
    Finance

    Amendment: SEC Form SCHEDULE 13D/A filed by GoHealth Inc.

    SCHEDULE 13D/A - GoHealth, Inc. (0001808220) (Subject)

    8/13/25 5:28:06 PM ET
    $GOCO
    Specialty Insurers
    Finance

    SEC Form SCHEDULE 13D filed by GoHealth Inc.

    SCHEDULE 13D - GoHealth, Inc. (0001808220) (Subject)

    8/13/25 5:27:38 PM ET
    $GOCO
    Specialty Insurers
    Finance

    $GOCO
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Kotte Vijay bought $100,275 worth of shares (7,500 units at $13.37), increasing direct ownership by 1% to 653,630 units (SEC Form 4)

    4 - GoHealth, Inc. (0001808220) (Issuer)

    11/15/23 10:10:34 AM ET
    $GOCO
    Specialty Insurers
    Finance

    $GOCO
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Credit Suisse resumed coverage on GoHealth with a new price target

    Credit Suisse resumed coverage of GoHealth with a rating of Underperform and set a new price target of $1.50

    4/1/22 7:10:27 AM ET
    $GOCO
    Specialty Insurers
    Finance

    GoHealth downgraded by RBC Capital with a new price target

    RBC Capital downgraded GoHealth from Outperform to Sector Perform and set a new price target of $2.00 from $10.00 previously

    3/3/22 4:36:13 AM ET
    $GOCO
    Specialty Insurers
    Finance

    GoHealth downgraded by Truist

    Truist downgraded GoHealth from Buy to Hold

    3/2/22 7:31:46 AM ET
    $GOCO
    Specialty Insurers
    Finance

    $GOCO
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13D/A filed by GoHealth Inc. (Amendment)

    SC 13D/A - GoHealth, Inc. (0001808220) (Subject)

    8/25/23 6:15:20 AM ET
    $GOCO
    Specialty Insurers
    Finance

    SEC Form SC 13D/A filed by GoHealth Inc. (Amendment)

    SC 13D/A - GoHealth, Inc. (0001808220) (Subject)

    8/25/23 6:03:57 AM ET
    $GOCO
    Specialty Insurers
    Finance

    SEC Form SC 13D/A filed by GoHealth Inc. (Amendment)

    SC 13D/A - GoHealth, Inc. (0001808220) (Subject)

    5/19/23 6:08:49 AM ET
    $GOCO
    Specialty Insurers
    Finance

    $GOCO
    Leadership Updates

    Live Leadership Updates

    View All

    Brendan Shanahan Appointed Chief Financial Officer of GoHealth, Bringing Decades of Leadership in Healthcare and Financial Strategy

    CHICAGO, Oct. 10, 2024 (GLOBE NEWSWIRE) -- GoHealth, Inc. (NASDAQ:GOCO), a leading health insurance marketplace and Medicare-focused digital health company, today announced the appointment of Brendan Shanahan as Chief Financial Officer (CFO), effective October 14, following a comprehensive search process. Mr. Shanahan, a seasoned executive with over 30 years of financial leadership experience and over 20 years of expertise in the Medicare Advantage space, will oversee GoHealth's financial strategy and operations, contributing to the company's profitable growth and innovation efforts. "Brendan's extensive expertise in financial strategy, M&A, operational leadership, and deep knowledge of t

    10/10/24 9:00:00 AM ET
    $GOCO
    Specialty Insurers
    Finance

    GoHealth Appoints Vance Johnston as Chief Financial Officer

    CHICAGO, Dec. 6, 2021 /PRNewswire/ -- GoHealth, Inc. (GoHealth) (NASDAQ:GOCO), a leading health insurance marketplace and Medicare-focused digital health company, announced today that Vance Johnston will join the Company as Chief Financial Officer (CFO) on December 7, 2021.  As previously announced, Travis Matthiesen, the Company's current CFO, will transition to the role of Chief Transformation Officer and will work closely with Johnston to ensure a smooth transition. "We are very pleased that Vance will be joining the GoHealth executive team as CFO," said Clint Jones, co-fou

    12/6/21 4:05:00 PM ET
    $GOCO
    Specialty Insurers
    Finance

    GoHealth Appoints Dr. Paul Hain, M.D. as Chief Medical Officer

    CHICAGO, Dec. 1, 2020 /PRNewswire/ -- GoHealth, Inc. (GoHealth) (NASDAQ: GOCO), a leading health insurance marketplace, announced today that Dr. Paul Hain, M.D. has joined the company as Chief Medical Officer. In this newly created role, Dr. Hain will work side-by-side with GoHealth's growing TeleCare team, directly building clinical functions within the recently developed Encompass Platform, a digital health solution that provides strategic value to GoHealth members and enterprise partners. Dr. Hain will focus on key member touchpoints including care management and navigation, provider and value-based care engagement, pharmacy engagement, health risk assessments, social determinant of he

    12/1/20 8:06:00 AM ET
    $GOCO
    Specialty Insurers
    Finance

    $GOCO
    Financials

    Live finance-specific insights

    View All

    GoHealth Announces Strategic Capital and Governance Actions to Support Long-Term Value Creation and Reports Second Quarter 2025 Results

    CHICAGO, Aug. 07, 2025 (GLOBE NEWSWIRE) -- GoHealth, Inc. (NASDAQ:GOCO) ("GoHealth" or the "Company"), a leading health insurance marketplace and Medicare-focused digital health company, today announced the execution of strategic capital and governance actions that are expected to significantly enhance its financial flexibility and long-term positioning along with its financial results for the three and six months ended June 30, 2025. Strategic Capital and Governance Actions Secured new senior secured superpriority term loan facility, including $80.0 million in new-money term loans and $35.0 million in roll-up loans, to support working capital and stra

    8/7/25 7:00:00 AM ET
    $GOCO
    Specialty Insurers
    Finance

    GoHealth to Announce Strategic Capital and Governance Actions to Support Long-Term Value Creation and Second Quarter 2025 Results

    CHICAGO, Aug. 06, 2025 (GLOBE NEWSWIRE) -- GoHealth, Inc. (GoHealth) (NASDAQ:GOCO), a leading health insurance marketplace and Medicare-focused digital health company, will announce strategic capital and governance actions to support long-term value creation and its second quarter 2025 financial results on the morning of August 7, 2025. Chief Executive Officer, Vijay Kotte, and Chief Financial Officer, Brendan Shanahan, will host a conference call and live audio webcast on the day of the release at 8:00 a.m. (ET) to discuss recent strategic capital and governance actions. A live audio webcast of the conference call will be available via GoHealth's Investor Relations websi

    8/6/25 4:15:00 PM ET
    $GOCO
    Specialty Insurers
    Finance

    GoHealth Reports First Quarter 2025 Results

    CHICAGO, May 13, 2025 (GLOBE NEWSWIRE) -- GoHealth, Inc. (NASDAQ:GOCO) ("GoHealth" or the "Company"), a leading health insurance marketplace and Medicare-focused digital health company, today announced financial results for the three months ended March 31, 2025. First Quarter Highlights First quarter 2025 net revenues of $221.0 million, a 19.1% increase compared to $185.6 million in the prior year period.First quarter 2025 net loss of $9.8 million, a 54.2% improvement compared to a net loss of $21.3 million in the prior year period.First quarter 2025 Adjusted EBITDA1 of $42.1 million, a 56.4% increase compared to $26.9 million in the prior year period.First quarter 2025 Submissions2 were

    5/13/25 7:00:00 AM ET
    $GOCO
    Specialty Insurers
    Finance